GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EDSA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Edesa Biotech, Inc. stock downgraded to Sell Candidate
(Updated on Apr 17, 2024)

Sell candidate since Apr 17, 2024 PDF

The Edesa Biotech, Inc. stock price gained 1.25% on the last trading day (Wednesday, 17th Apr 2024), rising from $4.35 to $4.40. During the last trading day the stock fluctuated 0.92% from a day low at $4.36 to a day high of $4.40. The price has fallen in 6 of the last 10 days but is still up by 0.92% over the past 2 weeks. Volume fell on the last day by -5 thousand shares and in total, 557 shares were bought and sold for approximately $2.45 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -8.32% during the next 3 months and, with a 90% probability hold a price between $3.62 and $4.89 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EDSA Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, March 21, 2024, and so far it has risen 7.58%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Edesa Biotech, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $4.44 and $4.43. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Edesa Biotech, Inc. stock

Edesa Biotech, Inc. finds support from accumulated volume at $4.36 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0400 between high and low, or 0.92%. For the last week the stock has had daily average volatility of 4.40%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EDSA) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Edesa Biotech, Inc. to open at $4.39, and during the day (based on 14 day Average True Range), to move between $4.08 and $4.72, which gives a possible trading interval of +/-$0.319 (+/-7.25%) up or down from last closing price. If Edesa Biotech, Inc. takes out the full calculated possible swing range there will be an estimated 14.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.36 (0.91%) than the resistance at $4.62 (4.95%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Edesa Biotech, Inc. stock A Buy?

Edesa Biotech, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -2.079 Sell Candidate Downgraded

Predicted Opening Price for Edesa Biotech, Inc. of Thursday, April 18, 2024

Fair opening price April 18, 2024 Current price
$4.39 ( 0.303%) $4.40

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EDSA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.43 0.606 %
R2 4.41 0.259 %
R1 4.40 0.0442 %
Current price: 4.40
Support S1 4.37 -0.650 %
S2 4.36 -0.86 %
S3 4.35 -1.21 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.12 16.36 %
R2 5.00 13.64 %
R1 4.62 4.95 %
Current price 4.40
Support S1 4.36 -0.91%
S2 4.18 -5.04%
S3 4.09 -7.05%

FAQ

What is the symbol for Edesa Biotech, Inc. Stock and on which exchange is it traded?
The symbol for Edesa Biotech, Inc. is EDSA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Edesa Biotech, Inc. Stock?
Edesa Biotech, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Edesa Biotech, Inc. Stock?
Edesa Biotech, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Edesa Biotech, Inc. Stock.

What's the current price of Edesa Biotech, Inc. Stock?
As of the end of day on the 2024-04-17, the price of an Edesa Biotech, Inc. (EDSA) share was $4.40.

What is the 52-week high and low for Edesa Biotech, Inc. Stock?
The 52-week high for Edesa Biotech, Inc. Stock is $8.33 and the 52-week low is $0.393.

What is the market capitalization of Edesa Biotech, Inc. Stock?
As of the 2024-04-17, the market capitalization of Edesa Biotech, Inc. is 13.956M.

When is the next earnings date for Edesa Biotech, Inc.?
The upcoming earnings date for Edesa Biotech, Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Edesa Biotech, Inc.

Edesa Biotech. Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chro... EDSA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT